Researcher
Arnaud Marchand
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Bioinformatics and computational biology
Affiliations
- Medicinal Chemistry (Rega Institute) (Division)
Member
From1 Oct 2000 → 30 Sep 2002
Publications
1 - 10 of 22
- Inhibitors of the Integrase–Transportin-SR2 interaction block HIV nuclear import(2018)
Authors: Jonas Demeulemeester, Jolien Blokken, Stéphanie De Houwer, Lieve Dirix, Arnaud Marchand, Patrick Chaltin, Frauke Christ, Zeger Debyser
- 1-((2,4-Dichlorophenethyl)Amino)3-Phenoxypropan-2-ol Kills Pseudomonas aeruginosa through Extensive Membrane Damage(2018)
Authors: Valerie Defraine, Veerle Liebens, Toon Swings, Bram Weytjens, Kathleen Marchal, Arnaud Marchand, Patrick Chaltin, Maarten Fauvart, Jan Michiels
- Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models(2017)
Authors: Valerie Defraine, Laure Verstraete, Arnaud Marchand, Patrick Chaltin, Maarten Fauvart, Jan Michiels
Pages: 2585 - Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa(2017)
Authors: Veerle Liebens, Valerie Defraine, Wouter Knapen, Toon Swings, Arnaud Marchand, Patrick Chaltin, Maarten Fauvart, Jan Michiels
- Discovery of a new Mycobacterium tuberculosis thymidylate synthase X inhibitor with a unique inhibition profile(2017)
Authors: Rania Abou El Asrar, Arnaud Marchand, Patrick Chaltin, Steven De Jonghe, Piet Herdewyn, Eveline Lescrinier
Pages: 69 - 78 - Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus(2016)
Authors: Joanna Zmurko, Suzanne Kaptein, Jef Rozenski, Bharat Gadakh, Patrick Chaltin, Arnaud Marchand, Johan Neyts, Arthur Van Aerschot
Pages: 158 - 168 - Elucidation of the mode of action of a new antibacterial compound active against Staphylococcus aureus and Pseudomonas aeruginosa(2016)
Authors: Evelien Gerits, Eline Blommaert, Bram Weytjens, Dries De Maeyer, Kathleen Marchal, Arnaud Marchand, Patrick Chaltin, Pieter Spincemaille, Katrijn De Brucker, Karin Thevissen, et al.
- Identification of drugs that restore primary cilium expression in cancer cells(2016)
Authors: Ali Talebi, Arnaud Marchand, Jonas Dehairs, Sebastian Munck, Patrick Chaltin, Johan Swinnen
Pages: 9975 - 92 - Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release(2015)
Authors: Kathi Held, Katrien De Clercq, Arnaud Marchand, Patrick Chaltin, Thomas Voets, Joris Vriens
Pages: E1363 - E1372 - 2-(2-Oxo-morpholin-3-yl)-acetamide Derivatives as Broad-Spectrum Antifungal Agents(2015)
Authors: Karin Thevissen, Katrijn De Brucker, Annelies Peeters, Patrick Chaltin, Bruno Cammue, Arnaud Marchand
Pages: 1502 - 1512
Patents
1 - 10 of 10
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)
- Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (Inventor)
- Aryl derivatives for treating trpm3 mediated disorders (Inventor)
- Tetrahydroquinoline derivatives as inhibitors of the yap/taz-tead activation for treating cancer (Inventor)
- Heterocycle derivatives for treating trpm3 mediated disorders (Inventor)
- Viral replication inhibitors (Inventor)
- Mono- or di-substituted indole derivatives as dengue viral replication inhibitors (Inventor)
- Substituted indoline derivatives as dengue viral replication inhibitors (Inventor)